about
Light chain (AL) amyloidosis: update on diagnosis and managementCD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapyImmunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatmentUtility of Doppler myocardial imaging, cardiac biomarkers, and clonal immunoglobulin genes to assess left ventricular performance and stratify risk following peripheral blood stem cell transplantation in patients with systemic light chain amyloidosiLong-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation.An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis.Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patientsMelphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trialRevised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.Treatment of plasma cell dyscrasias with lenalidomide.Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease.Left ventricular ejection time on echocardiography predicts long-term mortality in light chain amyloidosis.Clinical and imaging predictors of 1-year and long-term mortality in light chain (AL) amyloidosis: a 5-year follow-up studyState-of-the-Art Management of Complications of Myeloma and Its Treatment.Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management.Myocardial infarction with "clean coronaries" caused by amyloid light-chain AL amyloidosis: a case report and literature review.Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis.Role of high-dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis.Light-chain amyloidosis: SCT, novel agents and beyond.Immunoglobulin light chain amyloidosis.Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment.Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement.Amyloidosis relapsing after autologous stem cell transplantation treated with bortezomib: normalization of detectable serum-free light chains and reversal of tissue damage with improved suitability for transplant.Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006.Primary (AL) amyloidosis with gastrointestinal involvement.Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation.Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis.Autologous stem cell transplantation in light-chain amyloidosis patients: a single-center experience in KoreaAbstracts
P2860
Q21198863-A340C3BE-8D89-4980-91B3-9F3CDF6B6340Q24649764-55094FAE-3255-427C-B296-E82118F2150BQ26827340-344A0970-E555-4B5A-A363-E87251E8409AQ30469018-24414F90-5B3B-408D-A00C-BA7CD25AD652Q33292965-19153177-8CD2-45AA-AB88-F52976289E76Q33304297-D44EE9E5-DEC3-49A5-B494-0F6A458FFEB1Q34448455-95FD615E-FC5A-4AEA-BEE4-39498CE298C4Q35485742-C60C0A93-D99B-4466-9AEF-5C96A8A8CA3CQ36805878-AE12DCD1-65FF-4433-91E9-155A8649ACA6Q36910372-3595E42D-3173-432B-AB51-5739E4916C0BQ37176044-271FBC08-EC12-45C9-8D07-9A3C5216093EQ37246780-9028CF97-CB3C-42BC-937B-4B0A714860B8Q37456687-F79EA307-205A-449A-AF3E-6AD2AB379EF8Q37710999-886363C1-A2CA-47D8-BC2A-595BF5A64896Q37776662-9F9ADA50-BB9A-408C-829B-70F13E1F6DFEQ37832199-6297A789-4BD9-42DC-A8C7-943D7D47F3C7Q37866798-55CB415B-0503-448C-95D1-C6ABEA011564Q37904673-76FBCDF9-A813-4EEA-9E53-DA6947B2E60AQ37995198-DE99B367-70A5-434C-9F1E-A3759ADEA507Q38056010-F54F9F18-1AAA-46E9-A8FF-2C23A0480081Q38172295-99C0AB4A-72EE-4C9D-BA6A-7E539513E363Q38928383-7EACC682-27E0-4B9B-8204-EE4579D8A64CQ40973226-D6244A45-3057-4A1C-AC7D-DE1376E4ACAAQ42879120-11F85F39-11B4-43B1-B9B8-114C33F9C30AQ44468671-7032A501-6311-4063-9F39-AA4C42B006B1Q46109449-69865E04-463C-4D78-ACE2-C3CAFBF2880FQ46980729-6C3ACBEA-F13C-4E4C-9066-917A8F979145Q51683327-03B9E9C8-B36F-4DCD-A0A2-38A9EFC612A5Q53504425-B1D44FF0-AB58-4A7F-929C-58DE2F228395Q57223555-73D12718-3633-4B3C-A977-E1EDF2D44A6BQ57259399-17620D6E-505D-45EB-81A9-ECF8F2207AA7
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Transplantation for amyloidosis.
@ast
Transplantation for amyloidosis.
@en
type
label
Transplantation for amyloidosis.
@ast
Transplantation for amyloidosis.
@en
prefLabel
Transplantation for amyloidosis.
@ast
Transplantation for amyloidosis.
@en
P50
P1476
Transplantation for amyloidosis.
@en
P2093
Shaji Kumar
P304
P356
10.1097/CCO.0B013E32801494C6
P577
2007-03-01T00:00:00Z